JP2012500184A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500184A5
JP2012500184A5 JP2011507735A JP2011507735A JP2012500184A5 JP 2012500184 A5 JP2012500184 A5 JP 2012500184A5 JP 2011507735 A JP2011507735 A JP 2011507735A JP 2011507735 A JP2011507735 A JP 2011507735A JP 2012500184 A5 JP2012500184 A5 JP 2012500184A5
Authority
JP
Japan
Prior art keywords
amino acid
antigen
peptide
hla
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507735A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500184A (ja
JP5633025B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2009/003897 external-priority patent/WO2010021112A1/en
Publication of JP2012500184A publication Critical patent/JP2012500184A/ja
Publication of JP2012500184A5 publication Critical patent/JP2012500184A5/ja
Application granted granted Critical
Publication of JP5633025B2 publication Critical patent/JP5633025B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507735A 2008-08-19 2009-08-14 Hig2およびurlc10エピトープペプチドならびにそれを含むワクチン Active JP5633025B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8997208P 2008-08-19 2008-08-19
US61/089,972 2008-08-19
PCT/JP2009/003897 WO2010021112A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Publications (3)

Publication Number Publication Date
JP2012500184A JP2012500184A (ja) 2012-01-05
JP2012500184A5 true JP2012500184A5 (enExample) 2012-09-27
JP5633025B2 JP5633025B2 (ja) 2014-12-03

Family

ID=41707003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507735A Active JP5633025B2 (ja) 2008-08-19 2009-08-14 Hig2およびurlc10エピトープペプチドならびにそれを含むワクチン

Country Status (16)

Country Link
US (1) US9119800B2 (enExample)
EP (1) EP2328600B9 (enExample)
JP (1) JP5633025B2 (enExample)
KR (1) KR101713581B1 (enExample)
CN (2) CN104958753B (enExample)
AU (1) AU2009283763B2 (enExample)
BR (1) BRPI0917391A2 (enExample)
CA (1) CA2734467C (enExample)
DK (1) DK2328600T3 (enExample)
ES (1) ES2566011T3 (enExample)
IL (1) IL211117A (enExample)
MX (2) MX355054B (enExample)
RU (1) RU2529373C2 (enExample)
SG (2) SG10201610206VA (enExample)
TW (2) TWI580431B (enExample)
WO (1) WO2010021112A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
SI2640842T1 (sl) * 2010-11-17 2018-09-28 Aduro Biotech, Inc. Postopki in sestavki za induciranje imunskega odziva na EGFRvIII
US9644010B2 (en) 2012-07-10 2017-05-09 Oncotherapy Science, Inc. LY6K epitope peptides for TH1 cells and vaccines containing the same
RU2700881C2 (ru) 2014-08-04 2019-09-23 Онкотерапи Сайенс, Инк. Пептид, полученный из urlc10, и содержащая его вакцина
US11510971B2 (en) 2015-08-10 2022-11-29 Toray Industries, Inc. Immune inducer
AU2016306527B2 (en) 2015-08-12 2022-03-17 Oncotherapy Science, Inc. DEPDC1-derived peptide and vaccine containing same
AU2018258045B2 (en) 2017-04-26 2024-02-29 Eureka Therapeutics, Inc. Chimeric antibody/T-cell receptor constructs and uses thereof
JP7388798B2 (ja) 2017-06-20 2023-11-29 アンスティテュート キュリー Suv39h1を欠損する免疫細胞
CN115300609A (zh) * 2021-05-08 2022-11-08 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用
CN120842356A (zh) * 2025-07-25 2025-10-28 广西医科大学附属肿瘤医院 Ly6k抗原表位肽、组合物及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
ATE464383T1 (de) 1999-08-05 2010-04-15 Greenpeptide Co Ltd Tumor antigen
WO2001023426A2 (en) 1999-09-30 2001-04-05 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
CA2425569A1 (en) 2000-10-13 2002-04-18 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
US20030232350A1 (en) 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CN1882698B (zh) * 2003-08-20 2011-05-25 肿瘤疗法科学股份有限公司 低氧可诱导的蛋白2(hig2)作为新的治疗肾细胞癌(rcc)的潜在标靶
WO2005123122A1 (ja) * 2004-06-21 2005-12-29 Green Peptide Co., Ltd. 癌治療ペプチドワクチン
JP5109131B2 (ja) 2005-02-10 2012-12-26 オンコセラピー・サイエンス株式会社 膀胱癌を診断する方法
PL2325306T3 (pl) * 2005-02-25 2014-07-31 Oncotherapy Science Inc Szczepionki peptydowe do zastosowania w nowotworach płuc, wykazujących ekspresję polipeptydów TTK, URLC10 lub KOC1
EP1854473A1 (en) 2005-03-03 2007-11-14 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
WO2007013575A2 (en) 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
JP5116150B2 (ja) 2005-09-07 2013-01-09 日本電気株式会社 Hla結合性ペプチド、それをコードするdna断片および組み換えベクター
JP4840858B2 (ja) * 2006-03-16 2011-12-21 学校法人慶應義塾 癌ワクチン
CN105418751B (zh) 2006-06-16 2019-03-05 肿瘤疗法·科学股份有限公司 来自sparc的癌排斥抗原肽以及含有该肽的药物
TWI615403B (zh) 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
JP2010535014A (ja) 2007-07-30 2010-11-18 オンコセラピー・サイエンス株式会社 癌関連遺伝子ly6k
TW201000115A (en) 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Similar Documents

Publication Publication Date Title
Basile et al. The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
JP7687767B2 (ja) 呼吸器合胞体ウイルスワクチン
Liu et al. Engineering neoantigen vaccines to improve cancer personalized immunotherapy
JP2012500001A5 (enExample)
AU2016264623B2 (en) Shared neoantigens
JP2010519176A5 (enExample)
JP2010523471A5 (enExample)
JP2010506826A5 (enExample)
JP2014534202A5 (enExample)
RU2011110376A (ru) Эпитопные пептиды hig2 и urlc10 и содержание их вакцины
RU2011110504A (ru) Эпитопные пептиды inhbb и вакцины, содержащие данные пептиды
KR20180094859A (ko) 수두 대상포진 바이러스 (vzv)를 위한 핵산 백신
JP6786074B2 (ja) エキソソーム標的dnaワクチン
JP2009544614A5 (enExample)
CN122036892A (zh) 作为疫苗载体的三片段沙粒病毒
JP2011524737A5 (enExample)
JP2012517799A5 (enExample)
RU2011138160A (ru) Пептиды foxmi и вакцины, содержащие их
US20240026317A1 (en) PAN-RAS mRNA CANCER VACCINES
JP2019512020A5 (enExample)
JP2013523084A5 (enExample)
RU2012127358A (ru) Олигопептиды imp-3 и содержащие их вакцины
JP2016511221A5 (enExample)
JP2012520659A5 (enExample)
JP2014139185A5 (enExample)